(19)
(11) EP 3 723 859 A1

(12)

(43) Date of publication:
21.10.2020 Bulletin 2020/43

(21) Application number: 17851874.2

(22) Date of filing: 11.12.2017
(51) International Patent Classification (IPC): 
A61P 25/28(2006.01)
C07J 71/00(2006.01)
 A61K 31/585(2006.01)
(86) International application number:
PCT/IB2017/001758
(87) International publication number:
WO 2019/116070 (20.06.2019 Gazette 2019/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD TN

(71) Applicants:
  • Ethnodyne
    75008 Paris (FR)
  • CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE -CNRS-
    75016 Paris (FR)

(72) Inventors:
  • RABHI, Chérif
    91220 BRETIGNY SUR ORGE (FR)
  • CARIEL, Léon
    75006 PARIS (FR)
  • DA COSTA NOBLE, Christian
    75008 PARIS (FR)
  • OUAZZANI, Jamal
    91300 MASSY (FR)
  • ARCILE, Guillaume
    91940 LES ULIS (FR)
  • LE GOFF, Géraldine
    91940 Les Ulis (FR)

(74) Representative: Casalonga 
Casalonga & Partners Bayerstraße 71/73
80335 München
80335 München (DE)

   


(54) COMPOUNDS FOR TREATING NEURODEGENERATIVE DISORDERS